vimarsana.com

Latest Breaking News On - Birmingham medicine - Page 1 : vimarsana.com

Aileron Therapeutics and Pulmonary Care Experts To Discuss the Potential Implications of LTI-03 for Idiopathic Pulmonary Fibrosis in Virtual Key Opinion Leader Event

Aileron Therapeutics and Pulmonary Care Experts To Discuss the Potential Implications of LTI-03 for Idiopathic Pulmonary Fibrosis in Virtual Key Opinion Leader Event
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United-states
Cory-hogaboam
Tejaswini-kulkarni
Pergolizzi-jr
Fernandoj-martinez
Agaplesion-evang
Exchange-commission
Company-annual-report-on-form
Aileron-therapeutics-inc
Justus-liebig-university
Lung-therapeutics-inc
University-of-alabama-at-birmingham-medicine

Judge allows one final amendment of class action suit over Fabrazyme prescription drug shortage

PITTSBURGH – A federal judge has granted a final opportunity to amend a class action complaint, for plaintiffs who claimed significant harm was sustained on behalf of themselves and/or their loved ones, based on a shortage of a pharmaceutical drug named Fabrazyme that began in 2009 and lasted until 2012.

Germany
Ohio
United-states
Chicago
Illinois
Boston
Massachusetts
Versailles
New-york
University-of-washington
Washington
Seattle

Couple Welcomes Baby Born from Uterus Transplant Outside a Clinical Trial

A couple are now parents to the first baby born from a transplanted uterus outside of a clinical trial after participating in the University of Alabama at Birmingham Medicine's transplant program.

Alabama
United-states
University-of-alabama-at-birmingham
Anupam-agarwal
National-organization-for-rare-disorders
University-of-alabama-at-birmingham-medicine
Heersink-school-of-medicine
Birmingham-medicine
National-organization
Rare-disorders
Heersink-school

Study Underlines Potential of IL-6 Inhibitors for Polymyalgia Rheumatica

An analysis of Medcare claims data offers clinicians an overview or the effectiveness of sarilumab and tocilizumab in second- and third-line polymyalgia rheumatica treatments relative to conventional immunomodulators, such as methotrexate or azathioprine.

Polymyalgia-rheumatica
Jeffrey-curtis
University-of-alabama-at-birmingham
Drug-administration
Birmingham-medicine
Clinical-rheumatology
Steroid-refractory-polymyalgia-rheumatica
Published-april

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.